Drug recall D-1386-2019
Product
Ondansetron Injection, USP, 40 mg / 20 mL, 20 mL vial, Rx Only, Fresenius Kabi USA, LLC, Lake Zurich, IL 60047, NDC 63323-374-20
Reason for recall
Failed Impurities/Degradation Specifications.
Lots and codes
Lot #: 6018699, Exp. 12/2021
Recall details
- Recalling firm
- Fresenius Kabi USA, LLC, Grand Island, NY
- Quantity
- 11,981 units
- Distribution
- Nationwide within the United States
- Type
- Voluntary: Firm initiated
- Recall initiated
- May 22, 2019
- Terminated
- January 28, 2021
Related products
- Ondansetron – drug information
- NDC 63323-373 Ondansetron · Ondansetron Hydrochloride 2 mg/mL · Fresenius Kabi USA, LLC
- NDC 63323-374 Ondansetron · Ondansetron Hydrochloride 2 mg/mL · Fresenius Kabi USA, LLC